Related Experiment Videos
Risk factors for severe Chlamydia pneumoniae pneumonia in children: a retrospective case-control study
Di Hu1,2, Yingqian Zhang2,3,4, Ran Ma1,2
1Graduate School, Hebei Medical University, Shijiazhuang, Hebei, China.
Insights
In children with Chlamydia pneumoniae pneumonia (CPP), a lower lymphocyte percentage and elevated immunoglobulin A (IgA) are linked to severe disease. These findings may aid in identifying children at higher risk for severe CPP.
Area of Science:
- Pediatric infectious diseases
- Respiratory medicine
- Clinical microbiology
Background:
- Chlamydia pneumoniae pneumonia (CPP) is a significant cause of respiratory illness in children.
- Understanding risk factors for severe CPP is crucial for timely intervention and improved outcomes.
Purpose of the Study:
- To investigate the clinical features of CPP in children.
- To identify risk factors associated with the progression of CPP to severe pneumonia.
Main Methods:
- A retrospective study of 133 children diagnosed with CPP.
- Classification of disease severity based on established pediatric pneumonia guidelines.
- Comparison of demographic, clinical, and laboratory data between non-severe and severe CPP groups.
- Multivariate logistic regression to determine independent risk factors for severe CPP.
Main Results:
- Children with severe CPP exhibited higher peak temperatures and longer fever duration compared to those with non-severe CPP.
- Severe CPP cases showed a lower lymphocyte percentage and elevated white blood cell (WBC) count, C-reactive protein (CRP), and immunoglobulin A (IgA) levels.
- Multivariate analysis identified decreased lymphocyte percentage (OR=0.943) and elevated IgA (OR=2.227) as significant independent risk factors for severe CPP.
Conclusions:
- Reduced lymphocyte percentage and increased serum IgA levels are associated with severe CPP in children.
- These biomarkers may serve as potential indicators for risk stratification in pediatric CPP cases.
- Further multicenter prospective studies are recommended to validate these findings.
Objective:
This study aimed to investigate the clinical characteristics of Chlamydia pneumoniae pneumonia (CPP) in children and analyze the risk factors for progression to severe pneumonia.
Methods:
A total of 133 children with CPP were retrospectively enrolled from Hebei Children's Hospital between 2023 and 2025. Disease severity was classified according to the Guidelines for the Management of Community-Acquired Pneumonia in Children (2024 revision), and patients were divided into a non-severe group (n = 99) and a severe group (n = 34). Demographic characteristics, clinical manifestations, and laboratory findings were compared between groups. Multivariate binary logistic regression analysis was performed to identify independent factors associated with severe disease.
Results:
Compared with the non-severe group, children in the severe group had a higher peak temperature and longer duration of fever (both P < 0.001). No significant differences were observed in the proportion of mixed infections or the distribution of pathogens between the two groups (all P > 0.05). Laboratory findings showed a lower lymphocyte percentage and higher levels of WBC, CRP, and IgA in the severe group (all P < 0.05). Multivariate analysis identified decreased lymphocyte percentage (OR = 0.943, 95% CI 0.895-0.994) and elevated IgA (OR = 2.227, 95% CI 1.284-3.972) as factors associated with severe CPP.
Conclusion:
Decreased lymphocyte percentage and elevated serum IgA are associated with severe CPP in children, suggesting potential roles in risk stratification. Further multicenter prospective studies are warranted to validate and confirm these findings.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Atypical Pneumonia
Bacterial Phylum Chlamydiae
Chronic Obstructive Pulmonary Disease I: Introduction